圣淘沙名胜世界(新加坡)

    Crystallization of Enterovirus coxsackievirus A16 2A protease

    Peter Marples, Lizbé Koekemoer, Daren Fearon, ryan Lithgo

    Published: 2024-04-26 DOI: 10.17504/protocols.io.3byl49kdzgo5/v1
    AI 解读
    浏览 1683

    Disclaimer

    The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    Acknowledgements:

    Diamond Light Source Ltd, Harwell Science and Innovation Campus, Didcot OX11 0QX, UK

    Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK

    Oxford Lab Technologies crystal shifter http://doi.org/10.1107/S2059798320014114

    Abstract

    Picornaviridae coxsackievirus A16 is the causative agent of paediatric hand-foot-and-mouth disease, and a target for pandemic preparedness due to the risk of higher order complications in a large-scale outbreak. The 2A protease of the virus is responsible for self-cleavage from the poly protein, allowing for correct folding and assembly of capsid proteins in the final stages of viral replication. Inhibition deranges capsid folding and assembly, preventing formation of mature virions in host cells and making the protease a valuable target for antiviral activity. This protocol was used to grow coxsackievirus A16 crystals that were applied high-throughput crystallographic fragment screening on the target.

    Steps

    Equipment needed

    1.

    Formulatrix Rock Imager (or incubator of choice)

    SPT mosquito

    Equipment

    ValueLabel
    Mosquito HVNAME
    High Volume 16-Channel Robotic Liquid HandlerTYPE
    SPT LabTechBRAND
    3097-01057SKU

    P100 8 multi-channel pipette

    SwissCI 3 lens plate

    Crystallization experiment

    2.

    Prepare seed stock: seed stock:

    Diamond XChem Seeding Protocol1: 1000 dilution Sample seeds

    3.

    Protein and buffer requirements:

    43.2µL``20mg/mL``Sample

    3.36mL

    14.4µL Sample seeds, dilution 1:1000

    4.

    Crystallisation screen composition:

    13.5 % PEG 20000

    0.1Molarity (M) MES 6.7

    Stock solutions used:

    1Molarity (M) MES 6.7

    50% w/v PEG 20000

    Note
    The crystallisation screen can be stored in a duran bottle or aliquoted into 96 deep well block for easy dispensing into SwissCI 3 lens plates. For long term storage keep the Crystallisation screen in the fridge at 4°C.

    5.

    Dispense 35µL into SwissCI 3 lens plate reservoir wells using a 100 µl multi-channel pipette.

    Dispense 150``20mg/mL``Sample to each lens using the SPT mosquito.

    Dispense 150 to each lens using the SPT mosquito.

    Dispense 50 to each lens using the SPT mosquito.

    Drop ratio: 3:3:1 ratio (150 nl Sample : 150 nl reservoir solution: 50 nl seeds)

    Final drop volume: 350 nl

    6.

    Incubate at 20°C for 24h 0m 0s in Formulatrix Rock Imager.

    Imaging Schedule : The first images are taken after 12hrs and the imaging schedule follows a Fibonacci sequence of days for further collections.

    7.

    Crystal typically form after ~24hrs

    Citation
    Crystals typically reach their maximum size after ~24 h.Morphology: typically rectangles.Size: ~75 μm in length and ~10 μm in width, depth of the crystals is ~10 μm, giving arectangular appearanceAverage resolution: 1.6 ÅSpace group: C2Unit cell: 86 Å, 57 Å, 32 Å 90°, 95°, 90°
    An example of a drop containing Coxsackievirus A16 crystals.
    An example of a drop containing Coxsackievirus A16 crystals.

    Data collection at Synchrotron

    8.

    Diamond Light Source

    Unattended Data Collection (UDC)

    Data Collection Temperature: 100K

    Detector: DECTRIS EIGER2 X 9M

    Beamline: I04-1

    Wavelength: 0.9212 Å

    Resolution (Å): 1.21

    Beam Size (μm): 60 X 50

    Number of images: 3600

    Oscillation: 0.10°

    Exposure (s): 0.0020

    Transmission (%): 100

    Flux (ph/s): 9.50e+11

    推荐阅读

    Nature Protocols
    Protocols IO
    Current Protocols
    扫码咨询